Cite
HARVARD Citation
Viganò, M. et al. (n.d.). Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma. Digestive and liver disease. pp. e62-. [Online].